Epigenome-wide DNA methylation profiling in septic and non-septic patients with similar infections: potential use as sepsis biomarkers

IntroductionSepsis is a life-threatening condition caused by a dysregulated immune response to infection, leading to organ failure. Despite its significant global burden, the underlying mechanisms of immune dysfunction in sepsis remain incompletely understood. This study explores the role of DNA met...

Full description

Saved in:
Bibliographic Details
Main Authors: Ian López-Cruz, José Luis García-Giménez, Manuel Madrazo, Judit García-Guallarte, Laura Piles, Federico V. Pallardó, Arturo Artero
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2024.1532417/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589816784486400
author Ian López-Cruz
Ian López-Cruz
José Luis García-Giménez
José Luis García-Giménez
José Luis García-Giménez
Manuel Madrazo
Manuel Madrazo
Judit García-Guallarte
Laura Piles
Federico V. Pallardó
Federico V. Pallardó
Federico V. Pallardó
Arturo Artero
Arturo Artero
author_facet Ian López-Cruz
Ian López-Cruz
José Luis García-Giménez
José Luis García-Giménez
José Luis García-Giménez
Manuel Madrazo
Manuel Madrazo
Judit García-Guallarte
Laura Piles
Federico V. Pallardó
Federico V. Pallardó
Federico V. Pallardó
Arturo Artero
Arturo Artero
author_sort Ian López-Cruz
collection DOAJ
description IntroductionSepsis is a life-threatening condition caused by a dysregulated immune response to infection, leading to organ failure. Despite its significant global burden, the underlying mechanisms of immune dysfunction in sepsis remain incompletely understood. This study explores the role of DNA methylation in white blood cells in sepsis pathogenesis.MethodsA prospective case-control study was conducted to compare DNA methylation profiles between patients with community-acquired sepsis and matched controls who had similar infections but did not develop sepsis. Whole blood samples from these patients were analyzed using the Infinium MethylationEPIC v2.0 kit, enabling genome-wide methylation analysis. Selected genes with differential methylation were validated by pyrosequencing.ResultsSignificant differential DNA methylation patterns were identified between septic and non-septic individuals uising. Our results suggest that DNA methylation changes are closely linked to the pathophysiological processes of sepsis, influencing immune cell activation, inflammation, and organ dysfunction. The most prominent findings include the hypomethylation of immune-related genes (SERPINA1, AZU1, MPO, and SLX4), which were strongly correlated with clinical severity and inflammatory markers such as SOFA scores and PCT levels. Correlation analyses demonstrated significant associations between the methylation levels of these genes and clinical severity markers, such as SOFA score and PCT levels. Notably, SLX4 hypomethylation showed the highest predictive value for poor prognosis (AUC 0.821), while SERPINA1 hypomethylation exhibited strong diagnostic potential for sepsis (AUC 0.858).DiscussionOur results underscore the potential of DNA methylation changes, particularly in immune-related genes, to enhance the early detection of sepsis and to stratify patients based on severity. Future research should explore the therapeutic implications of these epigenetic alterations in sepsis care.
format Article
id doaj-art-124d9f461639416bb2434770238957e5
institution Kabale University
issn 2235-2988
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj-art-124d9f461639416bb2434770238957e52025-01-24T07:14:15ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882025-01-011410.3389/fcimb.2024.15324171532417Epigenome-wide DNA methylation profiling in septic and non-septic patients with similar infections: potential use as sepsis biomarkersIan López-Cruz0Ian López-Cruz1José Luis García-Giménez2José Luis García-Giménez3José Luis García-Giménez4Manuel Madrazo5Manuel Madrazo6Judit García-Guallarte7Laura Piles8Federico V. Pallardó9Federico V. Pallardó10Federico V. Pallardó11Arturo Artero12Arturo Artero13Department of Internal Medicine, Dr. Peset University Hospital, Valencia, SpainDepartment of Medicine, Faculty of Medicine & Dentistry, University of Valencia, Valencia, SpainDepartment of Physiology, Faculty of Medicine & Dentistry, University of Valencia, Valencia, SpainINCLIVA Biomedical Research Institute, Valencia, SpainCenter for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, Valencia, SpainDepartment of Internal Medicine, Dr. Peset University Hospital, Valencia, SpainDepartment of Medicine, Faculty of Medicine & Dentistry, University of Valencia, Valencia, SpainEpiDisease S.L., Parc Científic de la Universitat de València, Paterna, SpainDepartment of Internal Medicine, Dr. Peset University Hospital, Valencia, SpainDepartment of Physiology, Faculty of Medicine & Dentistry, University of Valencia, Valencia, SpainINCLIVA Biomedical Research Institute, Valencia, SpainCenter for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, Valencia, SpainDepartment of Internal Medicine, Dr. Peset University Hospital, Valencia, SpainDepartment of Medicine, Faculty of Medicine & Dentistry, University of Valencia, Valencia, SpainIntroductionSepsis is a life-threatening condition caused by a dysregulated immune response to infection, leading to organ failure. Despite its significant global burden, the underlying mechanisms of immune dysfunction in sepsis remain incompletely understood. This study explores the role of DNA methylation in white blood cells in sepsis pathogenesis.MethodsA prospective case-control study was conducted to compare DNA methylation profiles between patients with community-acquired sepsis and matched controls who had similar infections but did not develop sepsis. Whole blood samples from these patients were analyzed using the Infinium MethylationEPIC v2.0 kit, enabling genome-wide methylation analysis. Selected genes with differential methylation were validated by pyrosequencing.ResultsSignificant differential DNA methylation patterns were identified between septic and non-septic individuals uising. Our results suggest that DNA methylation changes are closely linked to the pathophysiological processes of sepsis, influencing immune cell activation, inflammation, and organ dysfunction. The most prominent findings include the hypomethylation of immune-related genes (SERPINA1, AZU1, MPO, and SLX4), which were strongly correlated with clinical severity and inflammatory markers such as SOFA scores and PCT levels. Correlation analyses demonstrated significant associations between the methylation levels of these genes and clinical severity markers, such as SOFA score and PCT levels. Notably, SLX4 hypomethylation showed the highest predictive value for poor prognosis (AUC 0.821), while SERPINA1 hypomethylation exhibited strong diagnostic potential for sepsis (AUC 0.858).DiscussionOur results underscore the potential of DNA methylation changes, particularly in immune-related genes, to enhance the early detection of sepsis and to stratify patients based on severity. Future research should explore the therapeutic implications of these epigenetic alterations in sepsis care.https://www.frontiersin.org/articles/10.3389/fcimb.2024.1532417/fullsepsisseptic shockDNA methylationepigeneticsbiomarkersinflammation
spellingShingle Ian López-Cruz
Ian López-Cruz
José Luis García-Giménez
José Luis García-Giménez
José Luis García-Giménez
Manuel Madrazo
Manuel Madrazo
Judit García-Guallarte
Laura Piles
Federico V. Pallardó
Federico V. Pallardó
Federico V. Pallardó
Arturo Artero
Arturo Artero
Epigenome-wide DNA methylation profiling in septic and non-septic patients with similar infections: potential use as sepsis biomarkers
Frontiers in Cellular and Infection Microbiology
sepsis
septic shock
DNA methylation
epigenetics
biomarkers
inflammation
title Epigenome-wide DNA methylation profiling in septic and non-septic patients with similar infections: potential use as sepsis biomarkers
title_full Epigenome-wide DNA methylation profiling in septic and non-septic patients with similar infections: potential use as sepsis biomarkers
title_fullStr Epigenome-wide DNA methylation profiling in septic and non-septic patients with similar infections: potential use as sepsis biomarkers
title_full_unstemmed Epigenome-wide DNA methylation profiling in septic and non-septic patients with similar infections: potential use as sepsis biomarkers
title_short Epigenome-wide DNA methylation profiling in septic and non-septic patients with similar infections: potential use as sepsis biomarkers
title_sort epigenome wide dna methylation profiling in septic and non septic patients with similar infections potential use as sepsis biomarkers
topic sepsis
septic shock
DNA methylation
epigenetics
biomarkers
inflammation
url https://www.frontiersin.org/articles/10.3389/fcimb.2024.1532417/full
work_keys_str_mv AT ianlopezcruz epigenomewidednamethylationprofilinginsepticandnonsepticpatientswithsimilarinfectionspotentialuseassepsisbiomarkers
AT ianlopezcruz epigenomewidednamethylationprofilinginsepticandnonsepticpatientswithsimilarinfectionspotentialuseassepsisbiomarkers
AT joseluisgarciagimenez epigenomewidednamethylationprofilinginsepticandnonsepticpatientswithsimilarinfectionspotentialuseassepsisbiomarkers
AT joseluisgarciagimenez epigenomewidednamethylationprofilinginsepticandnonsepticpatientswithsimilarinfectionspotentialuseassepsisbiomarkers
AT joseluisgarciagimenez epigenomewidednamethylationprofilinginsepticandnonsepticpatientswithsimilarinfectionspotentialuseassepsisbiomarkers
AT manuelmadrazo epigenomewidednamethylationprofilinginsepticandnonsepticpatientswithsimilarinfectionspotentialuseassepsisbiomarkers
AT manuelmadrazo epigenomewidednamethylationprofilinginsepticandnonsepticpatientswithsimilarinfectionspotentialuseassepsisbiomarkers
AT juditgarciaguallarte epigenomewidednamethylationprofilinginsepticandnonsepticpatientswithsimilarinfectionspotentialuseassepsisbiomarkers
AT laurapiles epigenomewidednamethylationprofilinginsepticandnonsepticpatientswithsimilarinfectionspotentialuseassepsisbiomarkers
AT federicovpallardo epigenomewidednamethylationprofilinginsepticandnonsepticpatientswithsimilarinfectionspotentialuseassepsisbiomarkers
AT federicovpallardo epigenomewidednamethylationprofilinginsepticandnonsepticpatientswithsimilarinfectionspotentialuseassepsisbiomarkers
AT federicovpallardo epigenomewidednamethylationprofilinginsepticandnonsepticpatientswithsimilarinfectionspotentialuseassepsisbiomarkers
AT arturoartero epigenomewidednamethylationprofilinginsepticandnonsepticpatientswithsimilarinfectionspotentialuseassepsisbiomarkers
AT arturoartero epigenomewidednamethylationprofilinginsepticandnonsepticpatientswithsimilarinfectionspotentialuseassepsisbiomarkers